Phoenix New Times:  “Target’s online store stopped selling hemp oil containing cannabidiol, a cannabis extract, on Thursday in the wake of concerns by the U.S. Drug Enforcement Agency about the products.  CW Hemp, makers of Charlotte’s Web high-cannabidiol (CBD), low-THC extract oil, announced Thursday morning that its products could be purchased through the retail giant’s website. According to the Cannabist web site, CW Hemp put out a press release on Thursday announcing that Target sold the products, claiming it meant CBD was ‘going mainstream.’ . . . But by Thursday afternoon, Target’s web page that sold the products was updated to reflect the products’ removal.”

Arizona Central:  “As an interior designer, Megan Stone’s job is to create a certain vibe or energy with visual cues and creative materials in a space.  But her specific area of expertise also involves breaking down and overcoming stereotypes. Stone must not only make her clients’ spaces customer-friendly, but in many cases also help her clients’ customers forget, even for a few minutes, everything they walked by or drove though to get there. . . . By 2015, Stone had designed dispensaries in seven states, she said. Now, her work is showcased in 15 states in 26 dispensaries. . . . TruMed dispensary had been operating for a year before it connected with Stone about three years ago, said Lauren Gooding, the registered nurse for TruMed.”

Daily Mail:  “Marijuana use does NOT affect teenager’s IQ, says new study (but it does make you dumber as an adult).  Using cannabis between 12 and 18 does not make an adolescent’s IQ decline
Children with low IQs are more likely to take the drug as teenagers. Cannabis does not have the suspected effects on brains and education. Researchers from Arizona State University analyzed 1,989 twins born in 1994-5. Past studies revealed cannabis use affects teenager’s educational achievements.”

Madison.com:  “A new market as large as $8.7 billion per year could open up in Canada in 2018. That’s the high end of the range projected by accounting and consulting firm Deloitte for the Canadian recreational marijuana market. Prime Minister Justin Trudeau is pushing to legalize recreational use of the drug by next summer. . . . Several marijuana growers already dominate the medical marijuana market in Canada and stand to benefit if the country legalizes recreational marijuana. The publicly traded companies on the list include Aphria, Aurora Cannabis, Canopy Growth, and MedReleaf. . . . Aphria owns part of Arizona medical marijuana provider Copperstate Farms.”

See Copperstate Farms, LLC.